Transcriptional Scenario of Altered Glycosylation in HPV-Associated Cervical Cancer

被引:0
|
作者
Thobias, Ashi R. [1 ]
Patel, Kinjal A. [1 ]
Mehta, Kruti A. [1 ]
Patel, Bijal M. [2 ]
Patel, Jayendra B. [1 ]
Patel, Prabhudas S. [1 ,3 ]
机构
[1] Gujarat Canc Res Inst, Canc Biol Dept, Ahmadabad 380016, Gujarat, India
[2] Gujarat Canc Res Inst, Dept Gynecol Oncol, Ahmadabad 380016, Gujarat, India
[3] Dr Jivraj Mehta Smarak & Hlth Fdn, Res Dept, Bakeri Med Res Ctr, Ahmadabad, Gujarat, India
关键词
Altered glycosylation; HPV; Cancer; ST6GAL-I;
D O I
10.1007/s12291-024-01280-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cervical cancer is one of the leading malignancies in women in India, with a high mortality rate and no available targeted therapy. This is due to a dearth of understanding of the underlying mechanisms regulating cervical carcinogenesis and the distinguished behavioral patterns of HPV-associated carcinomas. This study aims to understand the associations of HPV infection and cervical cancer with aberrant glycosylation, which is an enabling factor for other hallmarks of cancer. DNA and RNA were isolated from biopsy samples of 92 CC patients. HPV 16 and 18 infection was detected by endpoint type-specific PCR. The RNA samples were processed for expression analysis of the HPV 16-E6, HPV 16-E7 and HPV 16-E2 oncogenes. Analysis of the expression of glycosylated transcripts was performed via qPCR. HPV infection was correlated with the transcript levels of ST3GAL3, ST6GAL1, FUT5 and FUT8. In HPV 16- and 18-positive patients, the transcript levels of ST3GAL3, ST6GAL1 and FUT5 were increased, whereas FUT8 transcript levels were decreased. These data depict hyperglycosylation patterns associated with HPV infection. HPV-associated cancers show downregulation of core fucosylation and upregulation of ST3GAL3, ST6GAL1 and FUT5. The behavioral pattern of HPV-associated cancer could be due to its differential association with altered glycosylation.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] TCRγδ cells in HPV-associated cervical cancer
    Renoux, V
    De Leval, L.
    Waroux, O.
    Roncarati, P.
    Dortu, E.
    Cathy, R.
    Arafa, M.
    Boniver, J.
    Delvenne, P.
    Jacobs, N.
    ACTA CLINICA BELGICA, 2008, 63 (01): : 57 - 57
  • [2] HPV and HPV-associated cancer
    Liu, Xuefeng
    Wallace, Nick
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (10)
  • [4] Elimination of reserve cells for prevention of HPV-associated cervical cancer
    Reich, Olaf
    Regauer, Sigrid
    VIRUS RESEARCH, 2023, 329
  • [5] Antigen specific cancer immunotherapy for HPV-associated cervical cancers
    Lee, BP
    Kurman, RJ
    Pardoll, DM
    Wu, TC
    LABORATORY INVESTIGATION, 1997, 76 (01) : 602 - 602
  • [6] HPV-Associated bladder cancer
    Patterson, K.
    Daly, P.
    Cullen, I. M.
    BJU INTERNATIONAL, 2018, 122 : 43 - 43
  • [7] HPV-associated oropharyngeal cancer
    Sheedy, Trina
    Heaton, Chase
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 26 - 31
  • [8] Why De-Intensification is not Possible in HPV-Associated Cervical Cancer
    Beaty, Brian T.
    Cosper, Pippa F.
    Beriwal, Sushil
    Weiner, Ashley A.
    SEMINARS IN RADIATION ONCOLOGY, 2021, 31 (04) : 339 - 348
  • [9] Immunogenetic factors in HPV-associated cervical cancer: Influence on disease progression
    DugganKeen, MF
    Keating, PJ
    Stevens, FRA
    Sinnott, P
    Snijders, PJF
    Walboomers, JMM
    Davidson, S
    Hunter, RD
    Dyer, PA
    Stern, PL
    EUROPEAN JOURNAL OF IMMUNOGENETICS, 1996, 23 (04): : 275 - 284
  • [10] EFFECT OF CHLAMYDIA TRACHOMATIS INFECTION ON HPV-ASSOCIATED PATHOGENESIS OF CERVICAL CANCER
    Lu, Y. Y.
    Wu, Q.
    Wang, L.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 : 16 - 17